Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,766 public trials 495 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Minimal SN Tumor Burden

NCT01942603

Conditions: Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
Locations: U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium

CHRU de Lille Lille, France

CHU de Nice - Hopital De L'Archet Nice, France

Institut Gustave Roussy Paris, France

View all 22 locations

View Trial Details

Active, Not Recruiting

Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

NCT05270044

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Centro Oncologico Korben CABA, Buenos Aires, Argentina

Centro de Investigaciones Medicas Mar del Plata Mar del Plata, Buenos Aires, Argentina

Fundacion CIDEA Ciudad Autonoma Bs As, Ciudad Autonoma Buenos Aires, Argentina

Sanatorio Britanico S.A. Rosario, Santa Fe Province, Argentina

View all 155 locations

View Trial Details

Active, Not Recruiting

A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.

NCT02068196

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Ålesund Hospital Ålesund, Norway

Haukeland University Hospital Bergen, Norway

Nordland Hospital Bodø Bodø, Norway

Sørlandet Hospital, Kristiansand Kristiansand, Norway

View Trial Details

Active, Not Recruiting

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France

NCT04550247

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Lille, France

View Trial Details

Active, Not Recruiting

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients

NCT00553618

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: James Graham Brown Cancer Center Louisville, Kentucky, United States

View Trial Details

Active, Not Recruiting

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

NCT01586403

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Loyola University Medical Center Maywood, Illinois, United States

View Trial Details